Context Therapeutics Reports First Quarter 2023 Operating and Financial Results

Go back to Context Therapeutics Reports First Quarter 2023 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.38 -0.04 (9.52%)
Previous Close $0.42    52 Week High
Open $0.41    52 Week Low
Day High $0.42    P/E N/A 
Day Low $0.38    EPS
Volume 2,900,719